CSL Limited (ASX: CSL) shares, strong long-term performers, have faced unexpected tailwinds over the past few years, with the global pandemic impacting some of the company’s operations.

While COVID disruptions appear to be easing for the S&P/ASX 200 Index (ASX: XJO) biotech company, shakeups in the market have seen the CSL share price drop 7.2% this year, while the ASX 200 itself has slipped 6.4%.

However, looking ahead, Jun Bei Liu, portfolio manager at Tribeca Investment Partners, says investment in CSL shares could help “future-proof your portfolio”.

Fully funded and generating great cash flow

Speaking to Livewire, Liu said CSL shares top the list of ASX healthcare growth stocks she’s been buying.

She said CSL shares have “been hit early in this calendar year on the basis that everyone else was buying resources, and BHP Group Ltd (ASX: BHP) became such a big part of the index”.

Liu continued:

 Its earnings were hurt by the pandemic, simply because the blood collection was quite tough over the last few years. Now in its most recent update, CSL actually talked to that – it’s actually picking up quite quickly, which means earnings will grow quite significantly after that short term disruption.

To me, that business is trading on a very reasonable multiple for the growth it is going to deliver. And very similarly, the company is fully funded, generating really great cash flow. It’s really helping you to future-proof your portfolio.

Investors concerned about the impacts of rising interest rates and bond yields may also wish to investigate CSL shares.

According to Liu:

The bond yield, whether it’s peaked now or whether it’s in a month’s time or whether it’s further down the track, it doesn’t really matter. This is a quality growth company. Soon the market will come back to those companies and realise that everywhere else growth is going to be hard to deliver.

CSL shares also pay a 1.1% trailing dividend yield, unfranked.

How have CSL shares performed longer-term?

As long-term investors, it can pay to take a step back and study long-term performance.

With that in mind, CSL shares have gained 109% over the past five years, handily outpacing the 24% gains posted by the ASX 200 over that same period.

The post Why CSL shares are ‘going to deliver’ in 2022: fund manager appeared first on The Motley Fool Australia.

More reading

• ‘Future-proof your portfolio’: experts pick 3 quality growth ASX shares to buy
• Where next for the CSL share price?
• CSL share price cracks under Vifor Pharma acquisition delay
• Why CSL, Dicker Data, Lifestyle Communities, and Money3 shares are rising today
• What is driving the CSL share price higher today?

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/HTdACqz

The Australia and New Zealand Banking Group Ltd (ASX: ANZ) share price is edging higher today, up less than 1% at $25.60.

After starting the new year higher, ANZ shares have fluctuated over the last few months of trade. Prices have gyrated between a high of $28.75 in January and a low of $24.82 in March, a 16% spread.

Is the ANZ share price cheap?

Analysts at investment bank JP Morgan are overweight on ANZ shares and are tipping more upside for 2022 with a $30.30 price target.

The broker affirmed its view in a recent note, highlighting its “greater certainty in ANZ’s top line (revenue)”.

“ANZ offers the greatest exposure to rising offshore rates, stemming from its NZ franchise, and its large institutional business,” analysts wrote.

“It also has a large relative exposure to business lending, which should provide some protection from the severe short-term pressure on mortgage margins. While mortgage growth has been disappointing of late, we expect a gradual improvement in line with improved processing efficiencies.

“We expect ANZ will return to out-cost in FY23 as investment spend normalises. Capital management potential is at the upper end of the major banks.”

Meanwhile, analysts at Bloomberg Intelligence have echoed JP Morgan’s sentiment at the top, but reckon there could be a risk to ANZ’s net profit guidance.

The pair of Matt Ingram and Jack Baxter at Bloomberg reckon that “ANZ’s fiscal 2022 adjusted profit may fall 8-10%, as impairments rise from 2021’s A$567 million write-back and 1H’s A$284 million”.

“Costs may stay high as ANZ said investments would peak in fiscal 2022 and subsequent declines could be booked as savings, given inflation will make other cost cuts tricky and the A$8 billion target tough to hit,” the pair added.

Checking analyst recommendations provided by Bloomberg data reveals that 50% of coverage has ANZ rated as a buy, whereas roughly 44% have it as a hold.

The remaining 6% of analysts covering ANZ urge their clients to sell their positions.

In the last 12 months of trade, the ANZ share price has slipped 6% in the red. It’s also down around 7% over the past month.

The post Already down 7% in 2022, is the ANZ share price cheap? appeared first on The Motley Fool Australia.

More reading

• This is the best ASX bank share to buy in a rising rate environment: Citi
• How does the ANZ dividend compare to the other ASX 200 banks?
• What’s the outlook for ASX 200 bank shares amid rising interest rates?
• Is the ANZ share price a buy and a dividend opportunity?
• Why is the ANZ share price sliding on Monday?

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/4r5GEOn

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to stay in positive territory. At the time of writing, the benchmark index is up 0.2% to 7,108.7 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are sinking:

Brambles Limited (ASX: BXB)

The Brambles share price is down 8% to $10.70. Investors have been selling the logistics solutions company’s shares after it revealed that takeover talks with CVC Capital Partners have collapsed. Brambles will now focus on implementing the Shaping our Future transformation plan.

James Hardie Industries plc (ASX: JHX)

The James Hardie share price is down 3% to $37.61. This is despite the building materials company’s fourth quarter update revealing a 20% lift in quarterly global net sales to US$968 million. This underpinned a 24% year on year increase in James Hardie’s global net sales to US$3.6 billion for FY 2022. However, this was a touch short of consensus estimates.

Seek Limited (ASX: SEK)

The Seek share price is down 4% to $24.36. This may have been driven by the release of a bearish broker note out of Goldman Sachs. Its analysts have retained their sell rating and cut their price target on the job listings company’s shares to $26.60. Goldman is expecting strong earnings growth in FY 2022 but then an extremely sharp slowdown in FY 2023.

Sezzle Inc (ASX: SZL)

The Sezzle share price is down 6.5% to 64.5 cents. Investors have been selling this buy now pay later provider’s shares due to weakness in the tech sector. In addition, the re-release of its quarterly update may not be helping with sentiment. Several weeks after its initial release, Sezzle has reminded investors of its slowing growth and sizeable losses.

The post Why Brambles, James Hardie, Seek, and Sezzle shares are sinking appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to sell today
• Why is the Sezzle share price tumbling on Tuesday?
• ASX 200 midday update: Brambles takeover talks end, resources shares charge higher
• ‘Future-proof your portfolio’: experts pick 3 quality growth ASX shares to buy
• James Hardie share price stumbles despite 36% lift in annual sales

Motley Fool contributor James Mickleboro has positions in SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/7ujFhAP

The All Ordinaries Index (ASX: XAO) is higher today, but three ASX mining shares are outperforming the index.

The All Ordinaries Index is up 0.27% today to 7,345.8 points. For context, the S&P/ASX 200 Resources Index (ASX: XJR) is 1.25% higher at the time of writing, while the S&P/ASX 200 Materials Index (ASX: XMJ) is 0.86% in the green.

Let’s take a look at three ASX explorers doing well today.

Red 5 Ltd (ASX: RED)

The Red 5 share price is surging 9.09% today. Red 5 is exploring gold at the King of the Hills Gold Project in Western Australia. The spot gold price rebounded 0.8% overnight due to softening US bond yields. The company’s share price has leapt 5% since market close on 11 May. On 12 May, Red 5 revealed ore processing had started at the company’s King of the Hills project. Red 5 managing director Mark Williams said:

This is a key milestone for King of the Hills, delivered on time and on budget, and puts us on track for first gold production in the near future.

Renascor Resources Ltd (ASX: RNU)

The Renascor Resources share price is soaring 6.67% today. Renascor is developing the Siviour Graphite project in South Australia. Graphite is the anode material for batteries in electric vehicles (EV). The company’s share price appears to be jumping amid strong market sentiment among ASX graphite shares. The Novonix Ltd (ASX: NVX) share price is up 1.32% today, Syrah Resources Ltd (ASX: SYR) is leaping 5.62% and Black Rock Mining Ltd (ASX: BKT) is climbing 1.25%. Renascor raised $65 million via a share placement in late April to push expansion and development of the Siviour project.

Ioneer Ltd (ASX: INR)

The Ioneer share price is up 8.66% at the time of writing, settling from its intraday high of more than 10% higher. Ioneer is exploring the Rhyolite Ridge Lithium-Boron project in Nevada, USA. The company’s shares are rising amid strong lithium sentiment. ASX lithium explorers Mineral Resources Limited (ASX: MIN) and Core Lithium Ltd (ASX: CXO) are also up 5.36% and 7.17% respectively today. Lithium is a critical component in EV batteries. In a recent presentation in Sydney, Ioneer said its Rhyolite Ridge project is “ideally positioned” to serve the US battery supply chain.

The post 3 ASX All Ordinaries mining shares having a terrific Tuesday appeared first on The Motley Fool Australia.

More reading

• Does the ETFS Battery Tech & Lithium ETF (ACDC) pay dividends?
• Australian Strategic Materials share price sinks 12% following rally
• Are these 2 small ASX shares too cheap to ignore?
• Incannex share price pops 9% on FDA news
• Why BlueScope, OFX, Pilbara Minerals, and Step One shares are pushing higher

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/bLqdJp2

The ETFS Battery Tech & Lithium ETF (ASX: ACDC) is certainly one of the more interesting exchange-traded funds (ETFs) on the ASX to watch.

Lithium, green metals, and battery technology are all areas of investing that have seen an enormous level of investor interest over the past year or two. And this ETF covers this space in all its glory. Not to mention its eye-catching, high voltage ticker code.

The ACDC ETF has been around since September 2018. It invests in a basket of global shares that collectively cover battery technology and green metal producers. Some of its top holdings are ASX shares like Mineral Resources Limited (ASX: MIN) and Pilbara Minerals Ltd (ASX: PLS). But it also counts international giants like Lockheed Martin, Hyundai Electric, and Toshiba Corp.

Since its inception, investors have enjoyed some meaningful returns from this ETF. Since September 2018, ACDC units have averaged a return of 17.8% per annum. That’s despite a loss of 15.5% over the past six months.

But many investors like to invest for income as well as capital gains. So how does ACDC fare in this department? Does this ETF pay out dividend distributions?

ACDC: Does this ASX ETF pay dividends?

Well, the answer to that question is yes. ACDC does indeed pay dividend distributions. It does so once a year, usually on 15 July.

Its last dividend distribution was doled out on 15 July 2021. This was a payment of $6.31 per unit, which came with a small number of franking credits too. This gives the ETFS Battery Tech & Lithium ETF a trailing distribution yield of 7.68% on current pricing.

Take that with a grain of salt though. ETFs like ACDC can be inconsistent when it comes to their distributions. Although investors enjoyed this monster payout last year, the previous two years saw dividend distributions of 79.18 cents per unit and $1.24 per unit respectively.

We haven’t yet heard what kind of dividend distributions are coming investors’ way in 2022 yet. But it will be interesting to see what this ASX ETF comes up with this time.

The ETFA Battery Tech & Lithium ETF charges a management fee of 0.69% per annum.

The post Does the ETFS Battery Tech & Lithium ETF (ACDC) pay dividends? appeared first on The Motley Fool Australia.

More reading

• What is a megatrend and which ones are impacting ASX shares right now?

Motley Fool contributor Sebastian Bowen has positions in Lockheed Martin. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Lockheed Martin. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/rQy0OLu

The Australian Strategic Materials Ltd (ASX: ASM) share price is handing back all of Monday’s gains and then some today.

At the time of writing, the Australian Strategic Materials share price is $5.06. That’s 12% lower than its previous close and 3.78% lower than it was at the end of Friday’s session.

For context, the broader market is in the green today. Right now, the All Ordinaries Index (ASX: XAO) is recording a 0.17% increase.

Let’s take a look at what’s going on with the critical metals producer this week.

Australian Strategic Materials share price tumbles

Australian Strategic Materials’ shares are plunging back into the red on Tuesday.

It surged 9% yesterday after it exited a trading halt with news Korea’s KCF Energy is investing US$15 million ($21.44 million at today’s exchange rate) to buy new shares in the company for $8.90 apiece.

The Seoul-based company also agreed to revise the pair’s framework agreement and negotiate a five-year offtake agreement for the supply of 2,800 dry metric tonnes of NdFEB alloy from the Korean Metals Plant.

The framework negotiations will see the companies discussing more investments in the ASX-listed critical metals producer.  

Thus, today’s drop could be a simple market correction after yesterday’s buying frenzy.

This week’s movements included, shares in Australian Strategic Materials are trading 55% lower year to date. Though, they have gained 19% since this time last year.

The post Australian Strategic Materials share price sinks 12% following rally appeared first on The Motley Fool Australia.

More reading

• Here’s why the Australian Strategic Materials share price is surging 31% today
• Why is the Australian Strategic Materials share price frozen today?

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Y4dXRIJ

Plenty of small ASX shares have experienced volatility in 2022. Could they now be too cheap to ignore?

A business isn’t necessarily better value after dropping in price. There could be a worsening of trading conditions, meaning the lower share price could be justified.

It could also be important to note that the ASX share market, or specific businesses, could keep falling from here. There isn’t a rule about when a business will reach the bottom of its decline.

However, investors can only take advantage of good opportunities if they actually jump on them. Could the below two businesses be good ideas?

Shaver Shop Group Ltd (ASX: SSG)

Shaver Shop is an ASX retail share with a market capitalisation of $138 million, according to ASX. It is a specialty retailer of male and female personal grooming products. It wants to be the market leader of “all things related to hair removal”.

The company is expanding its product range into other areas like oral care, hair care, massage, air treatment, and beauty categories.

The Shaver Shop share price has fallen by more than 13% in the last month.

Despite all of the impacts from COVID-19 lockdowns, Shaver Shop achieved growth in certain financial metrics in the first half of FY22. Total sales grew by 2.8% to $127.1 million, while corporate store online sales increased by 37.2% to $51.6 million.

While the HY22 earnings per share (EPS) dropped by 9.8 to 10.6 cents, the dividend per share was increased by a large 40.6% to 4.5 cents per share.

The small ASX share thinks that it’s well placed to benefit from new COVID-19 era customers turning into loyal, repeat customers. It continues to target new store openings in Australia and New Zealand.

In the second half of FY22 to 17 February 2022, total sales increased 6.2% and online sales were up 23.8%.

The broker Ord Minnett thinks that the Shaver Shop share price is a buy, with a price target of $1.30. The broker thinks the FY23 grossed-up dividend yield is going to be 13.7%.

At the time of writing, Shaver Shop shares are changing hands for $1.04 apiece.

Dusk Group Ltd (ASX: DSK)

Dusk is also an ASX retail share. It has a market capitalisation of $134 million according to the ASX.

This business describes itself as an Australian specialty retailer of home fragrance products, both through its stores and online. It sells candles, ultrasonic diffusers, reed diffusers, and essential oils, as well as fragrance-related homewares.

The Dusk share price has dropped by 32% since the beginning of 2022. It recently announced that it wasn’t going ahead with the acquisition of Eroma.

While total sales went backwards in the first half of FY22 mostly due to lockdowns, there were some positive numbers. The pro forma gross profit margin increased from 67.7% in the prior corresponding period to 68% in HY22. The small ASX share also added six new stores to finish the period with a network of 128 stores.

It has a trailing grossed-up dividend yield of 13.2%.

Management sees expansion into New Zealand and a continued store rollout in Australia as opportunities.

However, the company warned that in the second half, consumer sentiment continued to be “soft”.

The post Are these 2 small ASX shares too cheap to ignore? appeared first on The Motley Fool Australia.

More reading

• 2 ASX dividend shares expected to pay HUGE yields in 2022

JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Dusk Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/9wOmdBC

The Incannex Healthcare Ltd (ASX: IHL) share price is soaring during mid-afternoon trade.

This follows the company’s positive pre-investigational new drug application (pre-IND) meeting with the United States Food and Drug Administration (FDA).

At the time of writing, the healthcare company’s shares are trading at 49.5 cents, up 8.79%.

FDA responds to IHL-42X pathway

According to the company’s announcement, Incannex reported it received positive feedback from the FDA pre-IND meeting regarding the regulatory pathway for its IHL-42X.

Incannex’s IHL-42X is a novel therapy that comprises dronabinol and acetazolamide. The medical therapy is targeted for the potential treatment of obstructive sleep apnoea (OSA) in adults.

In February, Incannex submitted a pre-IND meeting package and meeting request to the FDA. This included an overview of the development program and questions relating to regulatory requirements for opening an IND application.

To conduct clinical trials for any medical product in the United States, an IND must be opened.

The FDA provided “guidance on Incannex’s proposed long-term development strategy, as well as specific parameters to demonstrate safety and efficacy in phase 2 and 3 pivotal studies”, the company said.

Furthermore, the FDA agreed that Incannex doesn’t need to conduct studies in animals for opening an IND for IHL-42X. This will save time and cost to the company which can now proceed with the adjustment of clinical trial designs to open an IND.

What did management say?

Incannex chief scientific officer Dr Mark Bleackley welcomed the feedback, saying:

The FDA’s interest in IHL-42X as a potential therapy for OSA was extremely encouraging.

…The agency’s responses to the specific questions we posed allow us to revise our clinical trial protocols, to ensure that we are running highly efficient studies that generate the type and amount of data the FDA will require in a future marketing application.

The results from the pre-IND meeting will shape the IHL-42X development program over the coming months.

Incannex share price snapshot

Over the past 12 months, the Incannex share price has rocketed by around 83% in value.

However, year to date, its shares are down 20%.

The company’s shares reached a multi-year high of 75.5 cents in March, before giving up their gains.

On valuation metrics, Incannex has a market capitalisation of around $633 million.

The post Incannex share price pops 9% on FDA news appeared first on The Motley Fool Australia.

More reading

• Why CBA, Incannex, Judo Capital, and Orica shares are rising
• Here’s why the Incannex share price is rocketing 18% today
• Down 25% in a month, the Incannex share price is now halted. Here’s why
• How have ASX cannabis shares been performing so far in 2022?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/ywNUthR

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.15% to 7,104.6 points.

Four ASX shares that are climbing more than most today are listed below. Here’s why they are pushing higher:

BlueScope Steel Limited (ASX: BSL)

The BlueScope share price is up 2% to $17.91. This appears to have been driven by a broker note out of Goldman Sachs this morning. According to the note, the broker has upgraded this steel manufacturer’s shares to a buy rating with a $25.30 price target. Goldman commented: “Painted steel & comp analysis implies BSL undervalued.”

OFX Group Ltd (ASX: OFX)

The OFX share price is up 8.5% to $2.69. Investors have been buying this international payment services company’s shares following the release of its full-year results. OFX reported a net profit after tax of $24.5 million, which is double what it achieved a year earlier. This was driven by healthy margins and a strong performance in the corporate segment.

Pilbara Minerals Ltd (ASX: PLS)

The Pilbara Minerals share price is up 4.5% to $2.72. This follows a strong day of trade in the materials sector on Tuesday, which has seen a number of lithium miners charge higher. This has helped drive the S&P/ASX 200 Materials index 0.8% higher this afternoon.

Step One Clothing Ltd (ASX: STP)

The Step One share price has rebounded 38% to 29 cents. Bargain hunters appears to believe that this underwear retailer’s shares were oversold on Monday following the release of a disappointing trading update. The team at Morgans is sticking with Step One. This morning the broker retained its add rating. And even though it has taken an axe to its price target and cut it by 75% to 60 cents, this still implies major upside potential.

The post Why BlueScope, OFX, Pilbara Minerals, and Step One shares are pushing higher appeared first on The Motley Fool Australia.

More reading

• The Step One share price rocketed 35% today! Here’s why
• OFX share price soars 8% on record FY22 results
• Why is the Pilbara Minerals share price climbing today?
• 2 sold-off ASX shares essential for electric cars
• Own ASX lithium shares? Here’s a global expert’s outlook on lithium demand (and supply)

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/cj6uCmG

Yesterday we looked at three ASX shares brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with brokers right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:

Seek Limited (ASX: SEK)

According to a note out of Goldman Sachs, its analysts have retained their sell rating and cut their price target on this job listings giant’s shares to $26.60. This is despite the broker forecasting Seek to deliver EBITDA ahead of consensus estimates and up 57% year on year in FY 2022. Goldman doesn’t believe this strong growth will be sustained and is forecasting a modest 4% lift in FY 2023. In light of this, it feels its shares are expensive at the current level. The Seek share price is trading at $24.39 on Tuesday.

Wesfarmers Ltd (ASX: WES)

A note out of Citi reveals that its analysts have downgraded this conglomerate’s shares to a sell rating and cut their price target on them to $42.00. The broker has been looking at the retail sector and appears to have concerns over the impact that high fuel prices, rising interest rates, and the resumption of travel will have on consumer confidence. The Wesfarmers share price is fetching $49.73 this afternoon.

Xero Limited (ASX: XRO)

Analysts at UBS have retained their sell rating and cut their price target on this cloud accounting platform provider’s shares to $70.00. While Xero outperformed the broker’s revenue expectations, its subscriber numbers fell short and no operating leverage emerged. However, the main sticking point for the broker is the company’s lack of cash flow. UBS feels this makes its valuation stretched despite recent weakness. The Xero share price is trading at $86.18 today.

The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia.

More reading

• Why this fund manager is backing Xero shares for the rest of 2022
• ‘Future-proof your portfolio’: experts pick 3 quality growth ASX shares to buy
• 5 things to watch on the ASX 200 on Tuesday
• What’s dragging on the Wesfarmers share price on Monday?
• Leading brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has positions in SEEK Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Xero. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited and Xero. The Motley Fool Australia has recommended SEEK Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/TPKXa8F